title: Adherence strategies. FDA approves ddI generic version.
mesh_terms: D016049:Didanosine / Q000627:therapeutic use*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010349:Patient Compliance; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D018894:Reverse Transcriptase Inhibitors; D016049:Didanosine